Geron (GERN) Assets Average (2011 - 2026)
Geron's (GERN) quarterly Assets Average came in at $552.3 million in Q1 2026, down 4.46% year-on-year from $578.1 million in Q1 2025, and down 2.92% quarter-over-quarter from $569.0 million in Q4 2025.
Geron (GERN) Assets Average (2011 - 2026) Analysis & Trends
Geron has disclosed Assets Average across 16 years of filings, most recently posting $552.3 million for Q1 2026.
- Assets Average for Q1 2026 came in at $552.3 million, down 4.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $552.3 million (down 4.46% YoY), and the FY2025 annual result was $582.2 million, up 17.86% from the prior year.
- Assets Average came in at $552.3 million for Q1 2026 at Geron, down from $569.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $578.1 million in Q1 2025 to a low of $211.6 million in Q4 2022.
- The 5-year median for Assets Average is $438.1 million (2024), against an average of $418.4 million.
- Across the five-year window, Assets Average slipped 19.81% in 2022 and jumped 92.44% in 2023, its largest moves.
- Geron's Assets Average stood at $211.6 million in 2022, then jumped by 90.72% to $403.5 million in 2023, then advanced by 28.7% to $519.4 million in 2024, then increased by 9.55% to $569.0 million in 2025, then fell by 2.92% to $552.3 million in 2026.
- The last three Assets Average figures came in at $552.3 million (Q1 2026), $569.0 million (Q4 2025), and $561.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 660.38 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 552.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 552.33 Mn |
| Dec 31, 2025 | 568.96 Mn |
| Sep 30, 2025 | 561.29 Mn |
| Jun 30, 2025 | 558.82 Mn |
| Mar 31, 2025 | 578.12 Mn |
| Dec 31, 2024 | 519.37 Mn |
| Sep 30, 2024 | 447.17 Mn |
| Jun 30, 2024 | 465.74 Mn |
| Mar 31, 2024 | 438.08 Mn |
| Dec 31, 2023 | 403.55 Mn |
| Sep 30, 2023 | 414.16 Mn |
| Jun 30, 2023 | 420.09 Mn |
| Mar 31, 2023 | 307.73 Mn |
| Dec 31, 2022 | 211.59 Mn |
| Sep 30, 2022 | 235.38 Mn |
| Jun 30, 2022 | 218.29 Mn |
| Mar 31, 2022 | 212.23 Mn |
| Dec 31, 2021 | 227.57 Mn |
| Sep 30, 2021 | 240.64 Mn |
| Jun 30, 2021 | 255.39 Mn |